These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 12522881)
1. [Drugs against symptomatic, benign prostatic hyperplasia]. Johansen TE Tidsskr Nor Laegeforen; 2002 Oct; 122(26):2544-5. PubMed ID: 12522881 [No Abstract] [Full Text] [Related]
2. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. Lepor H; Williford WO; Barry MJ; Brawer MK; Dixon CM; Gormley G; Haakenson C; Machi M; Narayan P; Padley RJ N Engl J Med; 1996 Aug; 335(8):533-9. PubMed ID: 8684407 [TBL] [Abstract][Full Text] [Related]
3. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. McConnell JD; Roehrborn CG; Bautista OM; Andriole GL; Dixon CM; Kusek JW; Lepor H; McVary KT; Nyberg LM; Clarke HS; Crawford ED; Diokno A; Foley JP; Foster HE; Jacobs SC; Kaplan SA; Kreder KJ; Lieber MM; Lucia MS; Miller GJ; Menon M; Milam DF; Ramsdell JW; Schenkman NS; Slawin KM; Smith JA; N Engl J Med; 2003 Dec; 349(25):2387-98. PubMed ID: 14681504 [TBL] [Abstract][Full Text] [Related]
4. Benign prostatic hyperplasia (BPH). Harv Mens Health Watch; 2006 Aug; 11(1):3. PubMed ID: 17111474 [No Abstract] [Full Text] [Related]
5. Medical management of benign prostatic hyperplasia--are two drugs better than one? Vaughan ED N Engl J Med; 2003 Dec; 349(25):2449-51. PubMed ID: 14681512 [No Abstract] [Full Text] [Related]
12. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia. Agha AH; Roy JB; Culkin DJ; Lyon K Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332 [TBL] [Abstract][Full Text] [Related]
13. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia]. Pushkar' DIu; Kosko DV; Loran OB; Kan IaD; Sapozhnikov IM; Tevlin KP Urol Nefrol (Mosk); 1995; (4):32-5. PubMed ID: 7571199 [TBL] [Abstract][Full Text] [Related]
15. Medical treatment as an alternative to surgery in the management of benign prostatic hypertrophy. Bredin HC Ir Med J; 1996; 89(3):86, 88. PubMed ID: 8707527 [No Abstract] [Full Text] [Related]
16. Benign prostatic hyperplasia. Medical and minimally invasive treatment options. Oesterling JE N Engl J Med; 1995 Jan; 332(2):99-109. PubMed ID: 7527494 [No Abstract] [Full Text] [Related]
17. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate. Naslund MJ; Miner M Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044 [TBL] [Abstract][Full Text] [Related]
18. Re: an economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia. DiSantostefano RL; Biddle AK; Lavelle JP Can J Urol; 2005 Feb; 12(1):2508-9; author reply 2509-10. PubMed ID: 15777487 [No Abstract] [Full Text] [Related]